首页> 美国卫生研究院文献>Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie >The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients?
【2h】

The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients?

机译:肠道微生物组和心理健康:我们应该告诉我们的病人什么?:肠道微生物群和心理健康:我们应该告诉我们的病人什么?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The gut microbiome as a potential therapeutic target for mental illness is a hot topic in psychiatry. Trillions of bacteria reside in the human gut and have been shown to play a crucial role in gut–brain communication through an influence on neural, immune, and endocrine pathways. Patients with various psychiatric disorders including depression, bipolar disorder, schizophrenia, and autism spectrum disorder have been shown to have significant differences in the composition of their gut microbiome. Enhancing beneficial bacteria in the gut, for example, through the use of probiotics, prebiotics, or dietary change, has the potential to improve mood and reduce anxiety in both healthy people and patient groups. Much attention is being given to this subject in the general media, and patients are becoming increasingly interested in the potential to treat mental illness with microbiome-based therapies. It is imperative that those working with people with mental illness are aware of the rationale and current evidence base for such treatment strategies. In this review, we provide an overview of the gut microbiome, what it is, and what it does in relation to gut–brain communication and psychological function. We describe the fundamental principles and basic techniques used in microbiome–gut–brain axis research in an accessible way for a clinician audience. We summarize the current evidence in relation to microbiome-based strategies for various psychiatric disorders and provide some practical advice that can be given to patients seeking to try a probiotic for mental health benefit.
机译:肠道微生物组作为精神疾病的潜在治疗目标是精神病学的热门话题。数以千计的细菌存在于人的肠道中,并已通过影响神经,免疫和内分泌途径在肠道-大脑的交流中发挥关键作用。已显示患有各种精神疾病的患者,包括抑郁症,双相情感障碍,精神分裂症和自闭症谱系障碍,其肠道微生物组的组成具有显着差异。例如,通过使用益生菌,益生元或饮食变化来增强肠道中的有益细菌,有可能改善健康人和患者群体的情绪并减少焦虑。普通媒体已对该主题给予了极大关注,并且患者对使用基于微生物组的疗法治疗精神疾病的潜力越来越感兴趣。当务之急是与精神疾病患者打交道的人应了解这种治疗策略的理由和当前的证据基础。在这篇综述中,我们概述了肠道微生物组,它是什么,以及它与肠脑沟通和心理功能的关系。我们以一种易于使用的方式描述了微生物组-肠-脑轴研究中使用的基本原理和基本技术。我们总结了与针对各种精神疾病的基于微生物组的策略有关的当前证据,并提供了一些实用建议,可以为寻求尝试益生菌以改善心理健康的患者提供建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号